Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Gestational trophoblastic tumor
Trial Type:  Treatment
Results 1-9 of 9 for your search:
Start Over
Dactinomycin or Methotrexate in Treating Patients with Low-Risk Gestational Trophoblastic Neoplasia
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0275, NCI-2012-00250, CDR0000725211, PGOG-0275_A08PAMDREVW01, NCT01535053
Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: Sym013-01, NCI-2016-01802, NCT02906670
T-cell Depleted Stem Cell Boost in Improving Graft Function in Patients Who Have Undergone Stem Cell Transplant
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: 14-228, NCI-2015-00179, NCT02350777
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients
Status: Active
Phase: Phase II
Type: Treatment
Age: 2 and over
Trial IDs: CLFG316X2202, NCI-2016-01390, NCT02763644
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 to 99
Trial IDs: 105GTN201, NCI-2017-00335, NCT02664961
Afatinib in Treating Patients with Recurrent Stage I-IV HER2 Positive Uterine Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 1503015437, NCI-2017-00360, NCT02491099
Activated Immune Cells in Treating Patients with Hematologic Cancers That Have Relapsed after Donor Stem Cell Transplant
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: J1484, NCI-2015-00990, NCT02342613
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
Status: Active
Phase: Phase I
Type: Treatment
Age: 1 to 65
Trial IDs: BP-008, NCI-2016-01336, NCT02477878
Start Over